Skip to main content
. 2017 Apr 4;8(21):35165–35175. doi: 10.18632/oncotarget.16815

Figure 3. Relapse-free survival in AJCC stage III MAC patients.

Figure 3

SAC morphology (A) (P=0.035) and CIMP status (B) (P=0.009) were associated with relapse-free survival in AJCC stage III MAC patients.